www.pharmablog.nl

Weblog met nieuws over de pharmaceutische industrie

Archive for April, 2010

The Associated Press examines the ongoing free-trade negotiations between the EU and India - a country that according to PricewaterhouseCoopers currently “makes one-fifth of the world’s generics.” The negotiations “could make it harder for millions … across the developing world to get lifesaving drugs…
Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Lexicon Pharmaceuticals, Inc…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Takeda Pharmaceutical Company Limited (Takeda) announced that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and which has embarked in the field of companion diagnostics with a view to progressing in the area of personalised medicine, announced that it has started patient enrolment in its Phase I …
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Ophthotech Corp. (”Ophthotech”), a privately held biopharmaceutical company focused on developing ophthalmic therapies for back-of-the-eye diseases, announced that the first patient has been enrolled in its Phase II randomized, controlled clinical trial of E10030, an anti-PDGF aptamer, in combination with Lucentis® for the treatment of wet age-related macular degeneration (AMD)…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced that it has advanced into drug development a discovery research candidate directed against PCSK9 (proprotein convertase subtilisin/kexin type 9), an important new target for the treatment of high cholesterol…
    Lees meer..

  • 0 Comments
  • Filed under: Bio Industrie
  • Anthem Blue Cross has withdrawn the proposed huge rate increases that launched a national controversy when they became public earlier this year, and may have helped President Barack Obama’s health reform legislation make it over the finish line.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Baptist Health Foundation of San Antonio is providing a shot in the arm to Faith Family Clinic to help serve more of the working uninsured population.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • MinuteClinic, the retail health care division of CVS Caremark, is teaming with Catholic Healthcare West’s three Valley hospitals. The deal follows a trend of convenience care clinics continuing to carve out their niche, as they prepare for implementation of health care reform efforts.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • California’s stem cell research funding agency awarded $28 million, including nearly $8.7 million for Bay Area organizations.

    Lees meer..

  • 0 Comments
  • Filed under: 3